TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

por Semaan, Louie, Mander, Navneet, Cher, Michael L., Chinni, Sreenivasa R.
Publicado 2019

MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs

por Semaan, Louie, Zeng, Qingning, Lu, Yong, Zhang, Yi, Zreik, Mehdi Mohamad, Chamseddine, Mohamad Baqer, Chopp, Michael, Zhang, Zheng Gang, Moonka, Dilip
Publicado 2021

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis

por Conley-LaComb, M. Katie, Semaan, Louie, Singareddy, Rajareddy, Li, Yanfeng, Heath, Elisabeth I., Kim, Seongho, Cher, Michael L., Chinni, Sreenivasa R.
Publicado 2016

A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells.

por Sbrissa, Diego, Semaan, Louie, Govindarajan, Barani, Li, Yanfeng, Caruthers, Nicholas J., Stemmer, Paul M., Cher, Michael L., Sethi, Seema, Vaishampayan, Ulka, Shisheva, Assia, Chinni, Sreenivasa R.
Publicado 2018

Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical Trial

por Vaishampayan, Ulka N., Heilbrun, Lance K., Monk, Paul, Tejwani, Sheela, Sonpavde, Guru, Hwang, Clara, Smith, Daryn, Jasti, Pallavi, Dobson, Kimberlee, Dickow, Brenda, Heath, Elisabeth I., Semaan, Louie, Cher, Michael L., Fontana, Joseph A., Chinni, Sreenivasa
Publicado 2021